This is a covid-19/coronavirus related contract action for: organoplate graft, QTY: 25, part no. 6401-400-B.
Ended Purchase Order Awarded
- Contract number
- 75N95021P00070
- Awardee
-
Mimetas Operations US, CO. UEI M9RJXA9M7L68
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $29,075
Award facts
- Opportunity
-
- OrganoPlate Graft to be used for the NCATS ETB SARS-CoV-2 project Solicitation · 75N95021Q00041 · Posted Jan 4, 2021
- Contract value 100% obligated
- $29,075.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gaithersburg, MD 20878, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Mimetas Operations US, CO. for 25 units of the Organoplate Graft (part number 6401-400-B), a microfluidic 3D cell culture plate used in research related to SARS-CoV-2 and COVID-19. The $29,075.00 contract was awarded on a sole-source, non-competitive basis due to the unique technical capabilities of the Organoplate Graft. The award is not designated as a set-aside and is part of the agency's efforts to find therapeutic solutions for the COVID-19 pandemic.
Quick answers
Who was awarded contract 75N95021P00070?
75N95021P00070 was awarded to Mimetas Operations US, CO. by National Institute on Drug Abuse (National Institutes of Health) on January 7, 2021.
How much is contract 75N95021P00070 worth?
The government has obligated $29,075 on 75N95021P00070.
Which agency awarded contract 75N95021P00070?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00070, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00070 competed?
The extent of competition for 75N95021P00070 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award